Results 211 to 220 of about 213,470 (338)

Intranasal Naloxone During Recurrent Exercise in Individuals with Type‐1 Diabetes Mellitus: Evaluation of the Clinical Predictors of Pharmacokinetics and Exposure–Response

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Impaired awareness of hypoglycemia (IAH) impacts 25%–30% of individuals with type 1 diabetes mellitus (T1D), potentially leading to severe outcomes due to reduced symptom perception. Naloxone, a mu‐opioid receptor antagonist, shows promise as a preventive measure against IAH.
Omar N. Al Yacoub   +9 more
wiley   +1 more source

Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Recognition of benefits and adverse effects of therapies in earlier clinical trial phases could improve the safety, efficiency, and cost of clinical trials. Using four clinical trials representing a diverse set of diseases and drug classes (EXSCEL: exenatide/GLP‐1 RA, SUGAR‐DM‐HF: empagliflozin/SGLT2i, PRADA: epirubicin/anthracycline, and ...
Jessica Chadwick   +17 more
wiley   +1 more source

Allosteric communication mechanism in the glucagon receptor. [PDF]

open access: yesJ Biol Chem
van der Velden WJC   +2 more
europepmc   +1 more source

Mortality and cardiovascular disease after cholecystectomy in type 2 diabetes: A nationwide longitudinal cohort study

open access: yesJournal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
Abstract Background The long‐term effects of cholecystectomy on mortality and cardiovascular disease (CVD) in patients with diabetes have not been evaluated. In the present study, we investigated the longitudinal effects of cholecystectomy on mortality and CVD in a population‐based cohort with type 2 diabetes (T2D). Methods In total, 2 216 930 national
Han Na Jung   +6 more
wiley   +1 more source

GLP-1R in diabetes mellitus: from basic discovery to therapeutics development. [PDF]

open access: yesFront Pharmacol
Li S   +5 more
europepmc   +1 more source

Genetically‐targeted control of the spinal cord and peripheral nervous system

open access: yesJournal of Intelligent Medicine, EarlyView.
Application of genetically‐targeted stimulation for treating diseases or injuries outside the brain. Optogenetic and chemogenetic systems have been developed for dysfunction in the cochlea, spinal cord, dorsal root ganglia (DRGs), peripheral nerves, lower urinary tract, and enteric nervous system (ENS). Created with Biorender.com.
Anakaren Romero Lozano   +3 more
wiley   +1 more source

Retatrutide-A Game Changer in Obesity Pharmacotherapy. [PDF]

open access: yesBiomolecules
Katsi V   +4 more
europepmc   +1 more source

State‐of‐the‐art review of blenderized diets—Status and future directions

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract This state‐of‐the‐art review was produced by a multidisciplinary team composed of pediatric gastroenterology and nutrition healthcare providers to provide a comprehensive overview of the use of blenderized tube feeds (BTFs). The team developed 12 vital questions to address gaps in the current understanding and practice of using BTFs, then ...
Sharon Weston   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy